-+ 0.00%
-+ 0.00%
-+ 0.00%

Morgan Stanley Maintains Underweight on Aptiv, Lowers Price Target to $55

Benzinga·05/19/2025 14:27:34
Listen to the news
Morgan Stanley analyst Adam Jonas maintains Aptiv (NYSE:APTV) with a Underweight and lowers the price target from $60 to $55.